Innocan Pharma Corporation has announced the granting of a patent in India for its innovative liposomal CBD injection aimed at chronic pain management. This patent reinforces the company's proprietary technology in a growing pharmaceutical market.
Company Information
Company
INNOCAN PHARMA Corp
Location
1015, 926 - 5 AVENUE SW
Herzliya, Tel Aviv, Israel
About
Innocan is a pharmaceutical tech company that operates under two main segments: Pharmaceuticals and Consumer Wellness. In the Pharmaceuticals segment, Innocan focuses on developing innovative drug delivery platform technologies comprises with cannabinoids science, to treat various conditions to improve patients' quality of life. This segment involves two drug delivery technologies: (i) LPT CBD- loaded liposome platform facilitating exact dosing and the prolonged and controlled release of CBD into the blood stream. The LPT delivery platform research is in the preclinical trial phase for two indications: Epilepsy and Pain Management. (ii) CLX CBD-loaded exosomes platform that may hold the potential to provide a highly synergistic effect of regenerating and anti- inflammatory properties targeting the Central Nervous System (CNS). In the Consumer Wellness segment, Innocan develops and markets a wide portfolio of innovative and high-performance self-care products to promote a healthier lifestyle. Under this segment Innocan has established a Joint Venture by the name of BI Sky Global Ltd. that focuses developing on advanced targeted online sales. https://innocanpharma.com/
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment INNOCAN PHARMA Corp ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
HerzliyaBiotechnologyHealth CarePharmaceuticalpharmaceuticals